These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11320581)

  • 1. [The effect of influenza vaccine on the immune system in elderly persons].
    Trzonkowski P
    Pol Merkur Lekarski; 2001 Feb; 10(56):75-9. PubMed ID: 11320581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of inactivated influenza vaccine in children.
    Wright PF
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):200-5. PubMed ID: 17055371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination antibody titers.
    de Bruijn IA; Nauta J; Gerez L; Palache AM
    Virus Res; 2004 Jul; 103(1-2):139-45. PubMed ID: 15163502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza vaccine 2008-2009.
    Med Lett Drugs Ther; 2008 Oct; 50(1296):77-9. PubMed ID: 18833032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Subvirion glycoprotein vaccines for the prevention of influenza in children and late middle-aged and elderly persons (current research developments and prospects for their use)].
    Chumakov MP
    Vestn Akad Med Nauk SSSR; 1980; (12):71-81. PubMed ID: 7257579
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.
    Belshe R; Lee MS; Walker RE; Stoddard J; Mendelman PM
    Expert Rev Vaccines; 2004 Dec; 3(6):643-54. PubMed ID: 15606348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health benefits of universal influenza vaccination strategy.
    Viboud C; Miller M
    PLoS Med; 2008 Oct; 5(10):e216. PubMed ID: 18959475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 May; 58(19):521-4. PubMed ID: 19478718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
    Holland D; Booy R; De Looze F; Eizenberg P; McDonald J; Karrasch J; McKeirnan M; Salem H; Mills G; Reid J; Weber F; Saville M
    J Infect Dis; 2008 Sep; 198(5):650-8. PubMed ID: 18652550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the impact of childhood influenza vaccination programmes in England and Wales.
    Vynnycky E; Pitman R; Siddiqui R; Gay N; Edmunds WJ
    Vaccine; 2008 Sep; 26(41):5321-30. PubMed ID: 18647634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulating effect of influenza vaccination in the elderly differing in health status.
    Myśliwska J; Trzonkowski P; Szmit E; Brydak LB; Machała M; Myśliwski A
    Exp Gerontol; 2004 Oct; 39(10):1447-58. PubMed ID: 15501014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccine: the challenge of antigenic drift.
    Carrat F; Flahault A
    Vaccine; 2007 Sep; 25(39-40):6852-62. PubMed ID: 17719149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of anti-influenza vaccination in elderly persons].
    Myśliwska J
    Przegl Epidemiol; 2002; 56 Suppl 1():91-9. PubMed ID: 12194236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cold-adapted, live attenuated influenza vaccine.
    Glezen WP
    Expert Rev Vaccines; 2004 Apr; 3(2):131-9. PubMed ID: 15056039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccine recommendations for the 1995-96 season.
    J Ark Med Soc; 1995 Aug; 92(3):132-3. PubMed ID: 7673096
    [No Abstract]   [Full Text] [Related]  

  • 16. New vaccine approaches for seasonal and pandemic influenza.
    Palache B
    Vaccine; 2008 Nov; 26(49):6232-6. PubMed ID: 18674583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant vaccines for influenza virus.
    Tripp RA; Tompkins SM
    Curr Opin Investig Drugs; 2008 Aug; 9(8):836-45. PubMed ID: 18666031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and cellular immune responses to split-virion H5N1 influenza vaccine in young and elderly adults.
    Leroux-Roels I; Van der Wielen M; Kafeja F; Vandermeulen C; Lazarus R; Snape MD; John T; Carre C; Nougarede N; Pepin S; Leroux-Roels G; Hoppenbrouwers K; Pollard AJ; Van Damme P
    Vaccine; 2009 Nov; 27(49):6918-25. PubMed ID: 19761837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the reactivity, safety and immunogenicity of the polyvalent subunit "Grippovak SE-Azh" influenza vaccine in boarding houses for the elderly and disabled].
    Beregovskiĭ NA; Malyshkina LP; Serdiukova LP; Belousova NI; Velikiĭ VN
    Vestn Akad Med Nauk SSSR; 1985; (1):9-12. PubMed ID: 3156457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.